NCT01944436View on ClinicalTrials.gov

A Genetic and Perfusion Study of Response to Cognitive Enhancers in Lewy Body Disease

CompletedOBSERVATIONAL
Enrollment

57

Participants

Timeline

Start Date

September 30, 2006

Primary Completion Date

January 31, 2016

Study Completion Date

January 31, 2016

Conditions
Lewy Body Disease
Interventions
DRUG

Cholinesterase Inhibitors (Rivastigmine, Aricept, Galantamine)

Trial Locations (1)

M4N3M5

Sunnybrook Health Sciences Centre, Toronto

All Listed Sponsors
lead

Sunnybrook Health Sciences Centre

OTHER

NCT01944436 - A Genetic and Perfusion Study of Response to Cognitive Enhancers in Lewy Body Disease | Biotech Hunter | Biotech Hunter